NIR: slowing down Parkinson’s disease using intracranial photobiomodulation, ie “light medicine into the brain”
CEA-Leti's clinical trial aims to slow neurodegeneration using an intracerebral implant whose light emission protects neurons. The objective of the clinical trial is to establish the feasibility, safety and efficacy of this approach in order to adapt it to other neurodegenerative diseases, such as Alzheimer's.
Inject Power: ultra Miniaturized Rechargeable Micro Battery for Medical Devices
This startup, born in the early 2000s, relies on nearly 40 patents from the CEA laboratories. Thanks to its micro-batteries, it is now possible to measure, on demand and without patient intervention, intraocular pressure (glaucoma prevention), intracranial pressure (stroke and hydrocephalus monitoring) or cardiac pressure (hypertension...).
ADMIR: simplify, accelerate, and enhance the diagnosis
The ADMIR system, dedicated to analysis laboratories and hospitals, addresses a wide range of healthcare applications. It helps doctors, biologists and biochemists who are subjected to an increasing number of analyses in their daily practices and aims to reduce the time of an analysis by 100 while making it more reliable.
Snowpack: the first invisibility network overlay
Snowpack is a spin-off of CEA. Building on more than 5 years of R&D in network privacy and security, Snowpack builds and operates the first invisible network overlay (SNO) that provides a service beyond trust by design to anonymize and secure data exchanges over the Internet.
Inocel: putting technology at the forefront of the hydrogen revolution
Inocel aspires to become a key player in the global transition to clean energy. With their revolutionary fuel cell modules designed to offer maximum reliability and robustness, Inocel targets uses in three different segments: land and sea mobility, high performance cars and stationary applications.